Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€25.88

€25.88

-0.350%
-0.09
-0.350%
-
 
23.02.24 / Tradegate WKN: 578560 / Symbol: FSNUF / Name: Fresenius / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Fresenius SE & Co. KGaA Stock

Fresenius SE & Co. KGaA shows a slight decrease today, losing -€0.090 (-0.350%) compared to yesterday.
So far the community has only identified positive things for Fresenius SE & Co. KGaA stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Fresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.

Pros and Cons of Fresenius SE & Co. KGaA in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Fresenius SE & Co. KGaA vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Fresenius SE & Co. KGaA -0.350% -1.970% -0.843% -1.895% -8.389% -27.931% -46.880%
Fresenius SE & Co. KGaA ADR - -2.308% -0.781% -5.926% -9.286% -28.652% -48.374%
Fresenius Medical Care AG & Co KGaA ST -1.170% -9.033% -1.660% -5.200% -6.052% -38.665% -49.431%
Quest Diagnostics Inc. 1.210% 2.086% -2.166% -12.573% -5.587% 21.082% 50.828%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

As a professional financial analyst, it is imperative to delve into the financials of Fresenius (FSNUF) to uncover insights about the company's performance in the Healthcare Providers & Services industry. At first glance, it is apparent that the company has shown some growth in terms of overall assets and revenue, as well as maintaining a stable financial base. However, a comprehensive assessment requires a deeper analysis of the available data to identify potential pros and cons.

Steady asset growth: Over the years, Fresenius has shown a consistent increase in its total assets. Comparing the years 2020, 2021, and 2022, the total assets have risen from €66.65 billion to €71.96 billion, and finally to €76.41 billion. This growth indicates a positive trajectory in the company's financial position and its ability to expand its reach within the industry.

Revenue growth: Fresenius’s total revenue in its fourth-quarter 2022 financial report reached €10.64 billion. This is a commendable figure for companies in the healthcare sector, and this growth directly influences Fresenius's investment potential.

Comments

Buy Fresenius SE & Co. KGaA
Show more

Buy Fresenius SE & Co. KGaA
Show more

systinvest bought the security Fresenius SE & Co. KGaA in his wikifolio Aktienwertselektion mit System.
Show more

News

EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24693/Fresenius.svg.png
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023
Why Dialysis Stocks Plunged Today: https://g.foolcdn.com/editorial/images/750599/retired-man-undergoing-chemotherapy-cancer-health-sick.jpg
Why Dialysis Stocks Plunged Today

Shares of several major dialysis stocks plunged on Wednesday after Novo Nordisk (NYSE: NVO) indicated one of its diabetes treatments could also be used to treat chronic kidney disease.

Dialysis

Why Shares of Fresenius Medical Care Were Dropping on Wednesday: https://g.foolcdn.com/editorial/images/750606/senior-patient-looking-through-window-at-hospital.jpg
Why Shares of Fresenius Medical Care Were Dropping on Wednesday

Shares of Fresenius Medical Care (NYSE: FMS) were down more than 18% as of noon ET on Wednesday. The healthcare company's shares are up a little more than 5% so far this year. The drop came because